According to our results, the gene GATA3 appears to be the main target for silencing in the DNMT3B+ aggressive forms of breast cancer, with twice the frequency of deleterious somatic alterations compared to the other genes in our selection. This evidence concerns the gene DNMT3B and breast cancer.